These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18846007)

  • 21. CTLA-4 blockade in the treatment of rheumatoid arthritis: an update.
    Cutolo M; Sulli A; Paolino S; Pizzorni C
    Expert Rev Clin Immunol; 2016; 12(4):417-25. PubMed ID: 26679631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists.
    Isaacs JD
    Expert Opin Biol Ther; 2009 Dec; 9(12):1463-75. PubMed ID: 19916731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.
    Fiocco U; Sfriso P; Oliviero F; Pagnin E; Scagliori E; Campana C; Dainese S; Cozzi L; Punzi L
    Autoimmun Rev; 2008 Oct; 8(1):76-82. PubMed ID: 18718877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis.
    Scarsi M; Ziglioli T; Airo' P
    J Rheumatol; 2011 Oct; 38(10):2105-11. PubMed ID: 21807779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting lymphocyte co-stimulation: from bench to bedside.
    Felix NJ; Suri A; Salter-Cid L; Nadler SG; Gujrathi S; Corbo M; Aranda R
    Autoimmunity; 2010 Nov; 43(7):514-25. PubMed ID: 20429850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization.
    Koenders MI; Marijnissen RJ; Joosten LA; Abdollahi-Roodsaz S; Di Padova FE; van de Loo FA; Dulos J; van den Berg WB; Boots AM
    Arthritis Rheum; 2012 Jun; 64(6):1762-70. PubMed ID: 22213107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
    MMW Fortschr Med; 2008 Jun; 150(26-27):56-7. PubMed ID: 18683309
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis.
    McIntosh KR; Linsley PS; Drachman DB
    Cell Immunol; 1995 Nov; 166(1):103-12. PubMed ID: 7585970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis.
    Aarvak T; Natvig JB
    Arthritis Res; 2001; 3(1):13-7. PubMed ID: 11178123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct activation of murine resting T cells by con A or anti-CD3 Ig.
    Quintáns J; Yokoyama A; Evavold B; Hirsch R; Mayforth RD
    J Mol Cell Immunol; 1989; 4(4):225-35; discussion 235-7. PubMed ID: 2532886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen presentation by cells that are not of bone marrow origin.
    Geppert TD; Lipsky PE
    Reg Immunol; 1989; 2(1):60-71. PubMed ID: 2518360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
    Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
    Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cells of staphylococcal enterotoxin B-tolerized autoimmune MRL-lpr/lpr mice require co-stimulation through the B7-CD28/CTLA-4 pathway for activation and can be reanergized in vivo by stimulation of the T cell receptor in the absence of this co-stimulatory signal.
    Zhou T; Weaver C; Linsley PS; Mountz JD
    Eur J Immunol; 1994 May; 24(5):1019-25. PubMed ID: 7514125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells.
    Remans PH; Wijbrandts CA; Sanders ME; Toes RE; Breedveld FC; Tak PP; van Laar JM; Reedquist KA
    Arthritis Rheum; 2006 Oct; 54(10):3135-43. PubMed ID: 17009234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
    Sebbag M; Parry SL; Brennan FM; Feldmann M
    Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
    Ding L; Shevach EM
    Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
    Sherrer Y
    Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.